Ember Therapeutics, Inc.
OTC: EMBT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Joseph Hernandez
- Headquarters
- New York City, United States
- IPO year
- 2015
- Market cap
- $398.0
- Website
- https://www.embertx.com
Loading EMBT…
Loading profile data…Frequently asked questions about EMBT
What does Ember Therapeutics, Inc. (EMBT) do?
Ember Therapeutics, Inc. operates as a biopharmaceutical company currently in its clinical development phase. Its core mission involves exploring the therapeutic applications of bone morphogenetic protein-7 (BMP-7) to engineer regenerative treatments. These innovative therapies are designed to alter the course of osteoarthritis, reverse insulin...
Where does EMBT trade?
Ember Therapeutics, Inc. (EMBT) trades on the Other OTC.
What sector is EMBT in?
Ember Therapeutics, Inc. (EMBT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Ember Therapeutics, Inc.?
Joseph Hernandez is the chief executive officer of Ember Therapeutics, Inc. (EMBT).
Where is Ember Therapeutics, Inc. headquartered?
Ember Therapeutics, Inc. is headquartered in United States.
Does EMBT pay a dividend?
Ember Therapeutics, Inc. (EMBT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did EMBT go public?
Ember Therapeutics, Inc. (EMBT) completed its initial public offering in 2015.